Kwatra M M, Schreurs J, Schwinn D A, Innis M A, Caron M G, Lefkowitz R J
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Protein Expr Purif. 1995 Dec;6(6):717-21. doi: 10.1006/prep.1995.0001.
To obtain large quantities of pure human beta 2-adrenergic receptor (beta 2-AR) needed for structural studies, an efficient method for beta 2-AR purification was developed using a recombinant receptor with an eight amino acid epitope at its C-terminus. This epitope is recognized by KT3-monoclonal antibody. The epitope tagged beta 2-AR was expressed in Sf9 cells with a specific activity of 5-20 pmol/mg of membrane protein. The epitope-tagged and wild-type receptors had identical ligand binding properties. The tagged receptor was solubilized using dodecyl-beta-maltoside with a quantitative yield. Solubilized epitope-tagged receptors were partially purified by KT3-mAb immunoaffinity in 60-70% yield. Further purification of the receptors on an alprenolol-affinity column resulted in a homogenous preparation with an overall yield of > 30%. The purified receptor was concentrated to > 1 mg/ml without loss of ligand binding activity.
为了获得结构研究所需的大量纯人β2 - 肾上腺素能受体(β2 - AR),利用一种在其C末端带有八个氨基酸表位的重组受体开发了一种高效的β2 - AR纯化方法。该表位可被KT3单克隆抗体识别。带有表位的β2 - AR在Sf9细胞中表达,比活性为5 - 20 pmol/mg膜蛋白。带有表位的受体和野生型受体具有相同的配体结合特性。使用十二烷基 - β - 麦芽糖苷以定量产率溶解带有表位的受体。溶解的带有表位的受体通过KT3 - mAb免疫亲和进行部分纯化,产率为60 - 70%。在阿普洛尔亲和柱上进一步纯化受体,得到了纯度均一的制剂,总产率> 30%。纯化后的受体浓缩至> 1 mg/ml且不损失配体结合活性。